Conference Coverage

Medicare fumbles penalties for excess heart failure readmissions


 

AT THE AHA SCIENTIFIC SESSIONS

References

ORLANDO – When the Centers for Medicare & Medicaid Services imposes financial penalties on hospitals because of excess readmissions for heart failure, the agency gets it wrong nearly 30% of the time, Hung-Mo Lin, Sc.D. asserted at the American Heart Association scientific sessions.

The problem, she said, is that the agency’s 2012 Inpatient Prospective Payment System Final Rule relies on a formula for estimating the risk-standardized excess readmission ratio that doesn’t take into account the uncertainties surrounding the measurements.

©roobcio/Thinkstock

This has serious consequences in terms of the resultant substantial probability of hospital misclassification errors, according to Dr. Lin of the Icahn School of Medicine at Mount Sinai, New York.

How substantial is this error rate? To find out, Dr. Lin and her coworkers retroactively applied the CMS formula to roughly 1.5 million heart failure admissions at nearly 5,000 U.S. hospitals during 2005-2008, then developed confidence intervals for the individual hospitals’ excess readmission ratios and ran the numbers again, this time using the updated formula. They determined that the false-penalty rate was 27.5% for the 2,381 hospitals with an elevated excess admission ratio as defined by the current CMS formula.

Conversely, among the 2,549 hospitals that would have been labeled as good performers using the CMS formula and hence not subject to a punitive payment adjustment, 28.8% actually turned out to be poor performers with excessive heart failure readmissions. Those hospitals would have wrongly escaped penalties, she explained.

Hospital volume mattered. When the investigators stratified their results by hospital volume, they found that the probability of hospital misclassification was twice as great for small hospitals – that is, those in the two bottom quintiles for patient volume – compared to hospitals in the top quintile.

Dr. Lin reported having no financial conflicts regarding this health policy study.

bjancin@frontlinemedcom.com

Recommended Reading

AHA: Three measures risk stratify acute heart failure
MDedge Cardiology
AHA: Should BP targets be higher in asymptomatic aortic stenosis?
MDedge Cardiology
VIDEO: Beta-blocker prevented trastuzumab-related drop in LVEF
MDedge Cardiology
FDA cancels REMS for rosiglitazone
MDedge Cardiology
Beta-blocker prevents trastuzumab-related LVEF drop
MDedge Cardiology
Chagas disease: Neither foreign nor untreatable
MDedge Cardiology
The palliative path: Talking with elderly patients facing emergency surgery
MDedge Cardiology
Diet, exercise improved peak oxygen intake in obese HFpEF patients
MDedge Cardiology
Vegetarianism may protect against heart failure
MDedge Cardiology
Neurosurgery at the End of Life
MDedge Cardiology